I really want to thank everyone for sharing their
Post# of 148165
It helped me gain perspective and understand that we are not the only Biotech/HealthCare Growth company facing valuation challenges but so are other companies in our sector with regards to valuations which have been deeply discounted over the past 12 months. So regardless of our situation our stock price would not have performed as good as it could be given the current market sentiment towards our sector in general. So Good or bad...the downturn of our stock price has actually mirrored the biotech downturn as well.
I sure hope we hear good news this week! BUT I also think it might be a good idea to please put everything into perspective with regards to our current valuation given the current market appetite... as investors retreat from risk at the current time. But also know that this too will change hopefully sooner than later!
Hope everyone is enjoying the weekend as best as they can. Thanks again for your continued perspectives.